Culling the health tech herd

From: POLITICO Future Pulse - Wednesday Mar 15,2023 06:01 pm
Presented by Guardant Health: The ideas and innovators shaping health care
Mar 15, 2023 View in browser
 
Future Pulse

By Ruth Reader, Ben Leonard and Erin Schumaker

Presented by Guardant Health

TECH MAZE

WASHINGTON, DC - MAY 20: Newly redesigned $100 notes are printed at the Bureau of Engraving and Printing on May 20, 2013 in Washington, DC. The one hundred dollar bills will be released this fall and has new security features, such as a duplicating portrait of Benjamin Franklin and microprinting added to make the bill more difficult to counterfeit. (Photo by Mark Wilson/Getty Images)

It's getting harder for health tech firms to bring in the Benjamins. | Getty Images

The threat of economic cataclysm is in the air, following the failures of Silicon Valley and Signature banks.

For digital health companies, the growing sense of gloom follows a bleak 2022 during which venture capital investment in them fell by more than half, according to a report from industry analyst Pitchbook.

The biggest problem? Companies are under budget pressure and spending less on employee benefits.

Similarly, health systems are buying less technology as they continue to navigate financial challenges. Labor costs are up and patient volume is down, making operating margins tighter than ever, reports management consulting firm KaufmanHall.

“What a hospital or health system is willing to buy is a pretty narrow set of products,” said Rebecca Springer, who authored a report on the health tech market and is a senior health analyst at Pitchbook.

A bar graph showing declining venture capital investment in health tech companies in 2022.

Growth opportunities: Limited opportunities to sell exist, Springer said.

Health systems continue to need software that can help administrative staff find and resolve unpaid bills. They also need technology to assist with hiring, contract staff and retiring workers.

Meanwhile, investment in digital therapeutics and technologies designed to treat chronic conditions like pain and diabetes, as well as behavioral health issues, remains resilient.

Long view: Venture capitalists will likely invest in products with a clear path to profitability that health systems and insurers need.

“This is part of the broader dynamic that we’re seeing in venture where there’s less of a risk appetite, valuations are coming down, and we’re not going to have these very lucrative public exits,” said Springer.

She added that consolidation is coming. Companies with useful, albeit niche, products will likely be subsumed into bigger players. But those that can’t compete may be doomed to fail.

 

A message from Guardant Health:

49M individuals remain unscreened and are at increased risk of dying from CRC. Learn more.

 
WELCOME TO FUTURE PULSE

Pemaquid Point, New Harbor, Maine

Pemaquid Point, New Harbor, Maine | Shawn Zeller

This is where we explore the ideas and innovators shaping health care.

Cold water swimmer Adam Boggon, a doctor from England, examined enthusiasts' belief that donning a wetsuit and swimming in partially frozen lakes can help combat depression in a recent piece for Harvard Public Health.

His take: It may, but probably because it brings people together for fun and exercise. If you try it, start slow, he writes, and consider risks like cold shock and heart arrythmia.

Share any thoughts, news, tips and feedback with Ben Leonard at bleonard@politico.com, Ruth Reader at rreader@politico.com, Carmen Paun at cpaun@politico.com or Erin Schumaker at eschumaker@politico.com.

Send tips securely through SecureDrop, Signal, Telegram or WhatsApp.

Today on our Pulse Check podcast, host Megan Messerly talks with Katherine Ellen Foley about the Veterans Health Administration's announcement that it will cover Leqembi, a new Alzheimer’s drug that appears to slow the disease’s progression, and why the VHA’s decision differs from other federal agencies.

Play audio

Listen to today's Pulse Check podcast

 

A message from Guardant Health:

Advertisement Image

 
FOLLOW THE MONEY

A woman with her home care worker in New York. | Getty Images

The government's paying too much for at-home care, an expert panel contends. | Getty Images

7 percent

The amount the Medicare Payment Advisory Commission says Congress should cut Medicare reimbursements for at-home care.

Combine Covid’s toll on nursing home residents with most people’s preference for living at home as long as possible as they age, and it’s no wonder that at-home care is growing.

Most recently, it expanded at a 2.5 percent clip in 2021, according to a Medicare Payment Advisory Commission analysis of data from the Centers for Medicare and Medicaid Services.

But the commission, MedPAC, says the growth is not good for Medicare’s budget because the government pays providers too much for their services.

The commissioners, mainly medical school professors and health system executives, said Congress could save $10 billion over five years without affecting access to care by ordering a 7 percent cut in reimbursements.

“Medicare’s payments for home health services are too high, and the excess payments diminish the service’s value as a substitute for more costly services,” the commission said in a report to Congress it released Wednesday.

Industry shudders: MedPAC’s proposal is sure to draw criticism from advocates for and providers of home-based care.

And it’s not clear how Congress will react. Lawmakers have backed the extension of at-home care waivers through the end of 2024. The waivers enable hospitals to treat some emergency department and inpatient patients in their homes instead.

 

A message from Guardant Health:

Now with the over 20,000 patient ECLIPSE clinical study, Guardant’s latest innovative test has been validated for detecting CRC. Learn More.

 
 

DOWNLOAD THE POLITICO MOBILE APP: Stay up to speed with the newly updated POLITICO mobile app, featuring timely political news, insights and analysis from the best journalists in the business. The sleek and navigable design offers a convenient way to access POLITICO's scoops and groundbreaking reporting. Don’t miss out on the app you can rely on for the news you need, reimagined. DOWNLOAD FOR iOSDOWNLOAD FOR ANDROID.

 
 
INNOVATORS

National Institutes of Health James Shannon building on the campus of NIH in Bethesda, Md., Friday, Oct. 24, 2014. Appropriately called Building 1 or Shannon building was dedicated by President Franklin D. Roosevelt and serves as the administrative center for NIH. (AP Photo/Pablo Martinez Monsivais)

The one place ARPA-H can't be is on the NIH campus in Bethesda, Md. | AP

ARPA-H is zeroing in on a Washington home.

The year-old Advanced Research Projects Agency for Health, created by Congress in 2021 to fund ambitious moonshot initiatives considered too risky by the private sector, plans a base of operations in Washington or its suburbs.

ARPA-H Director Renee Wegrzyn announced the decision at a Tuesday briefing, but did not reveal the specific location. She said the General Services Administration is currently helping the agency choose an office to lease.

ARPA-H plans to announce two additional locations later this year. In a December law, Congress ordered it to set up offices in at least three places around the country, specifying that none of them could be the campus of ARPA-H’s parent agency, the National Institutes of Health, in Bethesda, Md., just outside the capital.

“Anyone in the biomedical space can tell you you need to stay close to your regulators, to your payers, and many of those folks are in the national capital region,” said Wegrzyn.

Why it matters: Several cities and states have waged a fierce battle to host ARPA-H, which Congress created in a December 2021 law. The localities believe ARPA-H will bring jobs and revenue and bolster their companies and universities as the new agency sponsors research projects that aim to transform health care.

So far, the agency has hired 100 employees for its first location, including its first two program managers: Paul Sheehan, a former program manager at DARPA, the defense agency on which ARPA-H is based; and Ross Uhrich, a surgeon and former Navy lieutenant commander who most recently was an assistant professor at the Uniformed Services University of the Health Sciences.

 

LISTEN TO POLITICO'S ENERGY PODCAST: Check out our daily five-minute brief on the latest energy and environmental politics and policy news. Don't miss out on the must-know stories, candid insights, and analysis from POLITICO's energy team. Listen today.

 
 
 

Follow us on Twitter

Ben Leonard @_BenLeonard_

Ruth Reader @RuthReader

Carmen Paun @carmenpaun

Erin Schumaker @erinlschumaker

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://www.politico.com/_login?base=https%3A%2F%2Fwww.politico.com/settings

This email was sent to by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Please click here and follow the steps to .

More emails from POLITICO Future Pulse

Mar 14,2023 06:01 pm - Tuesday

SVB’s collapse and health tech's reckoning

Mar 13,2023 06:02 pm - Monday

Your new medicine, brought to you by AI

Mar 10,2023 07:01 pm - Friday

Can't turn back time

Mar 09,2023 07:01 pm - Thursday

A drug cost stat falls out of favor

Mar 08,2023 07:02 pm - Wednesday

Congress’ latest opioid law isn’t enough

Mar 07,2023 07:02 pm - Tuesday

Two visions of telehealth’s future

Mar 06,2023 07:02 pm - Monday

A gut feeling about wastewater